Abbott Labs Files 8-K on Security Holder Vote Matters

Ticker: ABT · Form: 8-K · Filed: 2025-04-28T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: ABT

TL;DR

ABT filed an 8-K for a shareholder vote. Keep an eye on what they're voting on.

AI Summary

Abbott Laboratories filed an 8-K report on April 28, 2025, indicating a submission of matters to a vote of security holders. The report pertains to events occurring on April 25, 2025. Abbott Laboratories, incorporated in Illinois, is a pharmaceutical preparations company with its principal executive offices located at 100 Abbott Park Road, Abbott Park, IL.

Why It Matters

This filing signals that Abbott Laboratories is engaging in a process that requires shareholder approval, which could impact corporate governance or strategic decisions.

Risk Assessment

Risk Level: low — The filing is a standard procedural report and does not disclose any immediate financial risks or significant operational changes.

Key Players & Entities

FAQ

What specific matters are being submitted for a vote of security holders?

The filing indicates a submission of matters to a vote of security holders, but the specific details of these matters are not provided in this excerpt.

When was the report filed with the SEC?

The report was filed as of April 28, 2025.

What is the principal business of Abbott Laboratories?

Abbott Laboratories is in the Pharmaceutical Preparations industry, SIC code 2834.

In which state was Abbott Laboratories incorporated?

Abbott Laboratories was incorporated in Illinois.

What is the ticker symbol for Abbott Laboratories?

The ticker symbol for Abbott Laboratories is ABT.

From the Filing

0001104659-25-040201.txt : 20250428 0001104659-25-040201.hdr.sgml : 20250428 20250428161013 ACCESSION NUMBER: 0001104659-25-040201 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250425 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250428 DATE AS OF CHANGE: 20250428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 25880415 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 8-K 1 tm2513267d1_8k.htm FORM 8-K false 0000001800 Common Shares, Without Par Value ABT 0000001800 2025-04-25 2025-04-25 0000001800 us-gaap:CommonStockMember exch:XCHI 2025-04-25 2025-04-25 0000001800 us-gaap:CommonStockMember exch:XNYS 2025-04-25 2025-04-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares Common Shares, Without Par Value   ABT       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549       FORM  8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   April 25, 2025 Date of Report (Date of earliest event reported)     ABBOTT LABORATORIES (Exact name of registrant as specified in charter)       Illinois   1-2189   36-0698440 (State or other Jurisdiction   (Commission File Number)   (IRS Employer of Incorporation)       Identification No.)       100 Abbott Park Road Abbott Park , Illinois 60064-6400 (Address of principal executive offices)(Zip Code)   Registrant’s telephone number, including area code:  ( 224 ) 667-6100   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities Registered Pursuant to Section 12(b) of the Act:   Title of Each Class Trading Symbol(s) Name of Each Exchange  on Which Registered Common Shares, Without Par Value ABT New York Stock Exchange Chicago Stock Exchange, Inc.   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company   ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ¨             Item 5.07 — Submission of Matters to a Vote of Security Holders.   Abbott held its Annual Meeting of Shareholders on April 25, 2025. The following is a summary of the

View on Read The Filing